Valneva SE VALN
NASDAQ VALN
$6.91 -0.15 (-2.20%)
As of: Sep 4, 2026 · 3:14 PM EDT

Valneva SE (VALN) Long-Term Deferred Tax (2020 - 2026)

Valneva SE (VALN) posted Long-Term Deferred Tax of $9.1 million for Q1 2026, down 6.27% sequentially from $9.7 million in Q4 2025, and up 8.78% YoY from $8.4 million in Q1 2025.

Analysis

Valneva SE (VALN) Long-Term Deferred Tax (2020 - 2026) Analysis & Trends

Valneva SE has reported Long-Term Deferred Tax for 7 years, with the latest figure at $9.1 million in Q1 2026.

  • Quarterly Long-Term Deferred Tax rose 8.78% year-over-year to $9.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $9.1 million (up 8.78% YoY) and the FY2025 annual result came in at $9.7 million, down 6.77% from the prior year.
  • Long-Term Deferred Tax eased to $9.1 million in Q1 2026 per VALN's latest filing, from $9.7 million in the prior quarter.
  • Over five years, Long-Term Deferred Tax peaked at $223.6 million in Q4 2023 and troughed at $2.9 million in Q2 2022.
  • A 5-year average of $20.6 million and a median of $8.6 million in 2025 frame the typical range for Long-Term Deferred Tax.
  • The sharpest annual moves came in 2023 and 2024: Long-Term Deferred Tax jumped 3788.67% in 2023, then tumbled 95.41% in 2024.
  • Over 5 years, Long-Term Deferred Tax stood at $5.8 million in 2022, then jumped by 3788.67% to $223.6 million in 2023, then tumbled by 95.41% to $10.3 million in 2024, then dropped by 5.57% to $9.7 million in 2025, then retreated by 6.27% to $9.1 million in 2026.
  • According to Business Quant data, Long-Term Deferred Tax over the past three periods registered $9.1 million, $9.7 million, and $8.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.43 Bn 130.58 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.34 Bn 58.15 Bn 1.37 Bn
4 Moderna 57.98 Bn 52.85 Bn 52.00 Mn
5 Revolution Medicines 43.98 Bn 43.98 Bn -
6 BeOne Medicines 39.92 Bn 34.82 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.42 Bn 32.11 Bn 992.69 Mn
8 Royalty Pharma 28.42 Bn 27.58 Bn -
9 Insmed 27.36 Bn 26.20 Bn 358.27 Mn
10 Valneva SE 580.64 Mn 439.38 Mn 1.86 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 9.83 Mn
Mar 31, 2026 9.08 Mn
Dec 31, 2025 9.69 Mn
Sep 30, 2025 8.58 Mn
Jun 30, 2025 9.07 Mn
Mar 31, 2025 8.35 Mn
Dec 31, 2024 10.26 Mn
Sep 30, 2024 12.81 Mn
Jun 30, 2024 8.25 Mn
Mar 31, 2024 7.61 Mn
Dec 31, 2023 7.09 Mn
Sep 30, 2023 10.00 Mn
Jun 30, 2023 10.82 Mn
Mar 31, 2023 6.60 Mn
Dec 31, 2022 5.75 Mn
Sep 30, 2022 2.97 Mn
Jun 30, 2022 2.86 Mn
Mar 31, 2022 3.71 Mn
Dec 31, 2021 4.10 Mn
Dec 31, 2020 6.64 Mn